Co/sub 74/Fe/sub 6/B/sub 15/Si/sub 5/
In vitro toxicity of Fe<sub>m</sub>O<sub>n</sub>, Fe<sub>m</sub>O<sub>n</sub>-SiO<sub>2</sub> composite, and SiO<sub>2</sub>-Fe<sub>m</sub>O<sub>n</sub> core-shell magnetic nanoparticles
... characterization, Fe m O n -SiO 2 composite flake-like and SiO 2 -Fe m O n core-shell IONPs demonstrated spherical shape with mean diameter of 98 ± 22 and 101 ± 19 nm, respectively (Figure ...2B–E). ...
11
Effect of Fe<sub>3</sub>O<sub>4</sub>-magnetic nanoparticles on acute exercise enhanced KCNQ<sub>1</sub> expression in mouse cardiac muscle
... Forty-two mice were randomly assigned to either the non- exercised control group (n = 6) or exercise groups (n = 36). Thirty-six mice were placed into plastic cylinders (23 cm tall × 14 cm diameter) containing ...
8
Preparation of Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles coated with gallic acid for drug delivery
... different pH levels which are similar to the pH of the stomach and the pH of the blood. Generally, the pH of the stomach varies from 1–2 to 4–5. After eating, the stomach releases proteases and hydrochloric acid ...
12
The changes of T lymphocytes and cytokines in ICR mice fed with Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles
... Chemical Co, St. Louis, MO) for 68 hours at 37 ° C in a 5% humidified CO 2 ...(4, 5-dimethylthiazol-2-yl) 2, 5-diphe- nyltetrazolium bromide (MTT) ...
6
Fe<sub>3</sub>O<sub>4</sub>-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis
... ± 15% humidity, and 12 h light/dark cycle) and had free access to water and ...Then, Fe 3 O 4 -PLGA or Fe 3 O 4 -PLGA-cRGD NPs at a final dosage of 1 mg lyophilized powder dissolving 1 mL phosphate- ...
14
Cut-off value of FEV<sub>1</sub>/FEV<sub>6</sub> as a surrogate for FEV<sub>1</sub>/FVC for detecting airway obstruction in a Korean population
... /FEV 6 cut-off for predicting FEV 1 /FVC ,70% was 75% using receiver operating characteristic curve analyses (area under receiver operating char- acteristic curve .../FEV 6 showed .../FEV 6 ,75% ...
7
Biosafety evaluation of Janus Fe<sub>3</sub>O<sub>4</sub>-TiO<sub>2</sub> nanoparticles in Sprague Dawley rats after intravenous injection
... molecular weights. Immunoblots for expression of p38, p-p38, JNK, p-JNK, HO-1, ERK, c-Jun, cleaved caspase 3, Bcl2, Bax, P50, p53, Nrf2, Akt, and GAPDH were detected. All antibodies for Western blot in this study were ...
15
Synthesis of composite magnetic nanoparticles Fe<sub>3</sub>O<sub>4</sub> with alendronate for osteoporosis treatment
... of Fe 3 O 4 , Dex/Fe 3 O 4 , and Bis/Dex/Fe 3 O 4 was verified by XRD (Figure ...standard Fe 3 O 4 pattern published by ...Bis/Dex/ Fe 3 O 4 was smaller than that of Fe 3 O 4 ...
12
Reversal of multidrug resistance by magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice
... DNR; 5-BrTet combined with DNR; 5-BrTet and MNP-Fe 3 O 4 combined with DNR, ...tumors, 5-BrTet and MNP-Fe 3 O 4 combined with DNR signifi cantly suppressed growth of ...of 5-BrTet ...
6
Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells
... the Fe 3 O 4 , sterile normal saline was added to prepare mixed suspensions of different ...were 5, ...a 6-hour wait after the second injection, after which time the mice were killed by cervical ...
10
Effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4 </sub>and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells
... milk powder dissolved in Tris-buffered saline (TBS) at room temperature for one hour. The primary P-gp antibody was mouse monoclonal anti-human antibody (Neomarkers, Fremont, CA, USA). The secondary antibody was alkaline ...
8
Magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> enhance docetaxel-induced prostate cancer cell death
... were incubated with MgNPs-Fe 3 O 4 (1 µ g/mL, 10 µ g/mL, or 100 µ g/mL) for 24 hours in the absence or presence of N-acetylcysteine (NAC; 10 mM) (Sigma-Aldrich Co); NAC was added 3 hours before treatment ...
10
Biological responses to core–shell-structured Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy
... for Fe@Si NP intravenous adminis- tration: control group, low-dose 10 nm Fe@Si NP-exposure group (10L), low-dose 20 nm Fe@Si NP-exposure group (20L), high-dose 20 nm ...
16
Immobilized transferrin Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery
... with 5 mg EDC and 5 mg NHS for 30 minutes at room ...with 5 mg PLGA, then intermittently sonicated for 30 minutes at room ...with 5 mg EDC, 5 mg NHS, and 500 µ L DOX (2 ...containing ...
9
The effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> on immune function in normal ICR mice
... whether Fe 3 O 4 -MNPs can alter cytokine production patterns in peripheral blood, enzyme-linked immunosorbent assay was ...conducted. Fe 3 O 4 -MNPs altered the production of IL-2, INF- γ , and ...of ...
7
Multifunctional magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance
... daunorubicin, 5-bromotetrandrine (5-BrTet) and daunorubicin, Fe 3 O 4 -MNP, and Fe 3 O 4 -MNP coloaded with daunorubicin and 5-bromotetrandrine (Fe 3 O 4 ...
9
Effect of interaction of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> and artesunate on apoptosis of K562 cells
... Based on the results of cytotoxicity assay, the best combina- tion condition of ART with MNPs-Fe 3 O 4 (100:1 M/M) was used to measure the apoptosis rate. Briefly, after being treated with ART, MNPs-Fe 3 O ...
8
Sub-10 nm Cu<sub>5</sub>FeS<sub>4</sub> cube for magnetic resonance imaging-guided photothermal therapy of cancer
... (Cu 5 FeS 4 cube) with a mean diameter of 5 ± 1 nm based on a facile one-pot pyrolysis method has been prepared ...Cu 5 FeS 4 cube not only possesses strong NIR absorption like copper sulfide but ...
10
The effects of magnetite (Fe<sub>3</sub>O<sub>4</sub>) nanoparticles on electroporation-induced inward currents in pituitary tumor (GH<sub>3</sub>) cells and in RAW 264.7 macrophages
... to Fe 3 O 4 NPs (100 µ g/mL), there was a progressive decrease in the activity of MEP-induced channels, which occurred at the level of hyperpolarizing potentials ranging between − 80 and − 200 ...of Fe 3 O ...
10
Polyetherimide-grafted Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging
... 60%. Fe 3 O 4 @SiO 2 /PEI, Fe 3 O 4 @SiO 2 / PEI/Sc shRNA, or Fe 3 O 4 @SiO 2 /PEI/VEGF shRNA was incubated with the cells in serum-free medium for 6 hours, and then replaced with complete ...
13